I agree that this site is using cookies. You can find further informations here.
X
Mao, Xuehan
63  results:
Search for persons X
?
1

Development and validation of an individualized and weighte..:

Mao, Xuehan ; Yan, Wenqiang ; Mery, David...
American Journal of Hematology.  99 (2024)  4 - p. 523-533 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Clinical Benefit of Autologous Stem Cell Transplantation fo..:

Liu, Jiahui ; Yan, Wenqiang ; Fan, Huishou...
Cancer Research Communications.  3 (2023)  9 - p. 1770-1780 , 2023
Link: https://doi.org/10.1158/..
 
?
3

The age-dependent changes in risk weights of the prognostic..:

Du, Chenxing ; Li, Lingna ; Fan, Huishou...
Hematology.  28 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
4

P-173 Development and validation of an individualized and w..:

Yan, Wenqiang ; Mao, Xuehan ; David, Mery...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S130-S131 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Case Report: Therapeutic Use of Ibrutinib in a Patient With..:

Huang, Yuehua ; Wang, Yanying ; Yu, Fan...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
6

IgH translocation with undefined partners is associated wit..:

Mao, Xue‐Han ; Zhuang, Jun‐Ling ; Zhao, Duo‐Duo...
European Journal of Haematology.  105 (2020)  3 - p. 326-334 , 2020
Link: https://doi.org/10.1111/..
 
?
7

Multiple myeloma hinders erythropoiesis and causes anaemia ..:

Liu, Lanting ; Yu, Zhen ; Cheng, Hui...
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
8

The impact of response kinetics for multiple myeloma in the..:

Yan, Yuting ; Mao, Xuehan ; Liu, Jiahui...
Blood Advances.  3 (2019)  19 - p. 2895-2904 , 2019
Link: https://doi.org/10.1182/..
 
?
9

Multiple high-risk cytogenetic aberrations confer a progres..:

Mao, xuehan ; Xu, Yan ; Yan, yuting...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e83 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Real-world Outcomes of Chinese patients with high-risk Mult..:

Weiwei, Sui ; deng, shuhui ; An, gang...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e222 , 2019
Link: https://doi.org/10.1016/..
 
?
11

The prognostic value of 1q21 gain does not rely on the copy..:

Du, Chenxing ; An, gang ; Xu, Yan...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e62-e63 , 2019
Link: https://doi.org/10.1016/..
 
?
12

The impact of response kinetics following initial therapy f..:

Yan, yuting ; Mao, xuehan ; Jiahui, Liu...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e222-e223 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Monitoring the cytogenetic architecture of minimal residual..:

An, Gang ; Yan, Yuting ; Xu, Yan...
Leukemia.  34 (2019)  2 - p. 578-588 , 2019
Link: https://doi.org/10.1038/..
 
?
14

IgH translocations with undefined partners are associated w..:

Mao, xuehan ; Xu, Yan ; Yan, yuting...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e82-e83 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Tolerance, Kinetics, and Depth of Response for Subcutaneous..:

Xu, Yan ; Deng, Shuhui ; Mao, Xuehan...
Clinical Lymphoma Myeloma and Leukemia.  18 (2018)  6 - p. 422-430 , 2018
Link: https://doi.org/10.1016/..
 
1-15